PHASE-II TRIAL OF M-AMSA THERAPY IN REFRACTORY HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA - CANCER AND LEUKEMIA GROUP-B STUDY 7972

被引：0
|
作者：
RYBAK, ME
ANDERSON, JR
POULIN, RF
AMREIN, PC
CANELLOS, GP
GOTTLIEB, AJ
机构：
[1] HARVARD UNIV, SCH PUBL HLTH, BOSTON, MA 02115 USA
[2] SUNY UPSTATE MED CTR, SYRACUSE, NY 13210 USA
[3] MASSACHUSETTS GEN HOSP, BOSTON, MA 02114 USA
[4] HARVARD UNIV, SCH MED, DANA FARBER CANC INST, BOSTON, MA 02115 USA
来源：
CANCER TREATMENT REPORTS | 1986年 / 70卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1233 / 1234
页数：2
相关论文
共 50 条
  • [41] PHASE-II TRIAL OF AMSACRINE IN PATIENTS WITH HEPATOMA - A CANCER AND LEUKEMIA GROUP-B STUDY
    AMREIN, PC
    RICHARDS, F
    COLEMAN, M
    POULIN, RF
    HOLLAND, JF
    WEINBERG, V
    PERRY, M
    CANCER TREATMENT REPORTS, 1984, 68 (06): : 923 - 924
  • [42] PHASE-II TRIAL OF SPIROGERMANIUM IN BREAST ADENOCARCINOMA - A CANCER AND LEUKEMIA GROUP-B STUDY
    BUDMAN, DR
    GINSBERG, S
    PERRY, M
    WEINBERG, V
    SCHEIN, P
    HANSON, J
    COLEMAN, M
    WOOD, W
    CANCER TREATMENT REPORTS, 1982, 66 (08): : 1667 - 1668
  • [43] PHASE-II TRIAL OF 4'-(9-ACRIDINYLAMINO)METHANESULFON-M-ANISIDIDE (AMSA) IN THE TREATMENT OF ADVANCED NON-HODGKINS LYMPHOMA
    WARRELL, RP
    STRAUS, DJ
    YOUNG, CW
    CANCER TREATMENT REPORTS, 1980, 64 (10-1): : 1157 - 1158
  • [44] PHASE-II STUDY OF CYTARABINE AND ETOPOSIDE IN CHILDREN WITH REFRACTORY OR RELAPSED NON-HODGKINS-LYMPHOMA - A STUDY OF THE FRENCH-SOCIETY-OF-PEDIATRIC-ONCOLOGY
    GENTET, JC
    PATTE, C
    QUINTANA, E
    BERGERON, C
    RUBIE, H
    PEIN, F
    DEMAILLE, MC
    PHILIP, T
    RAYBAUD, C
    JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (04) : 661 - 665
  • [45] PHASE-II STUDY OF ACRIDINYL ANISIDIDE (M-AMSA)(NSC-249992) IN REFRACTORY ADULT ACUTE-LEUKEMIA
    WINTON, EF
    VOGLER, WR
    ROSE, KL
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 437 - 437
  • [46] PHASE-II TRIAL WITH M-CAVE-CEC AS A SALVAGE CHEMOTHERAPEUTIC REGIMEN FOR EARLY RELAPSED OR PRIMARY REFRACTORY HODGKINS-DISEASE
    VREUGDENHIL, G
    JONGENLAVRENCIC, M
    RAEMAEKERS, JMM
    DEPAUW, BE
    ANNALS OF HEMATOLOGY, 1994, 69 (06) : 303 - 306
  • [47] CARMUSTINE, CARBOPLATIN, ETOPOSIDE, BLEOMYCIN AND PREDNISONE (CCEBP) IN THE TREATMENT OF NON-HODGKINS-LYMPHOMA - A PHASE-II STUDY
    LANDYS, KE
    BERG, GEB
    MICHANEK, AMK
    LYMPHOLOGY, 1994, 27 : 777 - 780
  • [48] CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN REFRACTORY HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA - A DOSE-FINDING STUDY
    WHEELER, C
    ANTIN, JH
    CHURCHILL, WH
    COME, SE
    SMITH, BR
    BUBLEY, GJ
    ROSENTHAL, DS
    RAPPAPORT, JM
    AULT, KA
    SCHNIPPER, LE
    EDER, JP
    JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (04) : 648 - 656
  • [49] PHASE-II TRIAL OF ETOPOSIDE AND CISPLATIN FOR REFRACTORY SMALL CELL LUNG-CANCER - A CANCER AND LEUKEMIA GROUP-B STUDY
    GRAZIANO, SL
    LEE, K
    PROPERT, KJ
    TINSLEY, R
    HAYES, DM
    GREEN, M
    COMIS, RL
    MEDICAL AND PEDIATRIC ONCOLOGY, 1990, 18 (01): : 22 - 26
  • [50] 2ND MALIGNANT NEOPLASMS IN PATIENTS SUCCESSFULLY TREATED FOR HODGKINS-DISEASE - A CANCER AND LEUKEMIA GROUP-B STUDY
    GLICKSMAN, AS
    PAJAK, T
    GOTTLIEB, A
    NISSON, N
    STUTZMAN, L
    COOPER, M
    CANCER TREATMENT REPORTS, 1982, 66 (04): : 1059 - 1059
12345